Iovance Biotherapeutics (IOVA) Cash & Equivalents (2009 - 2026)
Iovance Biotherapeutics (IOVA) reported Cash & Equivalents of $110.8 million for Q2 2026, down 16.4% from $132.47 million a year earlier and down 43.6% from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Iovance Biotherapeutics posted Cash & Equivalents of $163.08 million, up 41.0% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 19.4% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $115.69 million in FY2024 (+0.7%), $114.89 million in FY2023 (-50.4%), $231.73 million in FY2022 (+196.2%) and $78.23 million in FY2021 (+16.2%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q2 2022.
- Year over year, Cash & Equivalents gained in four of the last eight quarters, with an average decline of 2.1%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2023 (growth of 488.4%); the low point was Q1 2024 (a decline of 75.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $196.51 million (Q1 2026), $163.08 million (Q4 2025) and $158.13 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Iovance Biotherapeutics | 3.74 Bn | 2.45 Bn | 73.44 Mn | 57.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 57.93 Mn |
| Jun 30, 2026 | 110.80 Mn |
| Mar 31, 2026 | 196.51 Mn |
| Dec 31, 2025 | 163.08 Mn |
| Sep 30, 2025 | 158.13 Mn |
| Jun 30, 2025 | 132.47 Mn |
| Mar 31, 2025 | 171.67 Mn |
| Dec 31, 2024 | 115.69 Mn |
| Sep 30, 2024 | 164.19 Mn |
| Jun 30, 2024 | 228.68 Mn |
| Mar 31, 2024 | 134.19 Mn |
| Dec 31, 2023 | 114.89 Mn |
| Sep 30, 2023 | 267.72 Mn |
| Jun 30, 2023 | 230.01 Mn |
| Mar 31, 2023 | 543.48 Mn |
| Dec 31, 2022 | 231.73 Mn |
| Sep 30, 2022 | 118.37 Mn |
| Jun 30, 2022 | 108.08 Mn |
| Mar 31, 2022 | 92.36 Mn |
| Dec 31, 2021 | 78.23 Mn |
API Access
Iovance Biotherapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();